Department of Emergency Medicine, AZ Alma, Eeklo, Belgium.
Department of Pharmacy, Ghent University Hospital, Ghent, Belgium.
PLoS One. 2020 Dec 3;15(12):e0243222. doi: 10.1371/journal.pone.0243222. eCollection 2020.
Disulfiram is an adjunct in the treatment of alcohol use disorders, but case reports indicate that disulfiram ethanol reactions are not always recognized in the emergency department. Our first aim is to remind of this risk with two case reports of life-threatening reactions not immediately considered by the emergency physician. The second aim is to estimate the probability that a disulfiram reaction goes unrecognized with the use of a retrospective study of patients admitted to the emergency department.
Clinical files of patients admitted between October 1, 2010 and September 30, 2014 to the emergency department were retrospectively screened for the key words "ethanol use" and "disulfiram". Their diagnoses were then scored by a panel regarding the probability of an interaction.
Seventy-nine patients were included, and a disulfiram-ethanol reaction was scored as either 'highly likely', 'likely' or 'possible' in 54.4% and as 'doubtful' or 'certainly not present' in 45.6% of the patients. The interrater agreement was 0.71 (95% CI: 0.64-0.79). The diagnosis was not considered or only after a delay in 44.2% of the patients with a 'possible' to 'highly likely' disulfiram interaction. One patient with a disulfiram overdose died and was considered as a 'possible' interaction.
A disulfiram ethanol interaction can be life threatening and failure to consider the diagnosis in the emergency department seems frequent. Prospective studies with documentation of the intake of disulfiram and evaluation of the value of acetaldehyde as a biomarker are needed to determine the precise incidence. Improving knowledge of disulfiram interactions and adequate history taking of disulfiram intake may improve the care for patients.
双硫仑是治疗酒精使用障碍的辅助药物,但病例报告表明,急诊科并不总能识别出双硫仑乙醇反应。我们的第一个目的是通过两例危及生命的反应的病例报告来提醒这种风险,这两例反应并未立即被急诊医生识别。第二个目的是通过对急诊科收治的患者进行回顾性研究来估计未被识别出的双硫仑反应的概率。
回顾性筛选 2010 年 10 月 1 日至 2014 年 9 月 30 日期间收入急诊科的患者的临床档案,使用关键词“乙醇使用”和“双硫仑”进行搜索。然后,由一个专家组对这些诊断进行评分,以确定是否存在相互作用的可能性。
共纳入 79 例患者,54.4%的患者被评为双硫仑-乙醇反应“高度可能”、“可能”或“有可能”,45.6%的患者被评为“可疑”或“肯定不存在”。组内一致性为 0.71(95%置信区间:0.64-0.79)。在诊断为“可能”至“高度可能”的双硫仑相互作用的 44.2%患者中,该诊断未被考虑或仅在延迟后才被考虑。1 例双硫仑过量患者死亡,被认为是“可能”的相互作用。
双硫仑乙醇相互作用可能危及生命,在急诊科未考虑该诊断似乎很常见。需要进行前瞻性研究,记录双硫仑的摄入情况,并评估乙醛作为生物标志物的价值,以确定确切的发病率。提高对双硫仑相互作用的认识并充分了解双硫仑的摄入情况,可能会改善对患者的治疗。